[1]
A. Dworzanska, “The role of toll-like receptor 9 (TLR9) in Epstein-Barr virus-associated gastric cancer”, Curr. Issues Pharm. Med. Sci., vol. 33, no. 2, pp. 106–111, Jun. 2020, doi: 10.2478/cipms-2020-0020.